Last reviewed · How we verify
Turmeric Extract
At a glance
| Generic name | Turmeric Extract |
|---|---|
| Also known as | turmeric |
| Sponsor | Zagazig University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance. (PHASE2, PHASE3)
- Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma (PHASE1)
- Curcumin in Critically Ill Patients With Sepsis (NA)
- Effectiveness and Safety of Benemix® in Constipation (NA)
- Curcumin in Combination With 5FU for Colon Cancer (EARLY_PHASE1)
- Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome (NA)
- Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs) (EARLY_PHASE1)
- The Effectiveness of a Herbal Supplement in Osteoarthritis. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Turmeric Extract CI brief — competitive landscape report
- Turmeric Extract updates RSS · CI watch RSS
- Zagazig University portfolio CI